Wiley Blackwell

SHERPA: Unknown

People

  1. Horwitz
    Horwitz
  2. Moskowitz
    Moskowitz
  3. Palomba
    Palomba
  4. Zelenetz
    Zelenetz
  5. Noy
    Noy
  6. Kumar
    Kumar
  7. Dogan
    Dogan
  8. Hamlin
    Hamlin
  9. Yahalom
    Yahalom
  10. Schoder
    Schoder

Groups

  1. Center for Hematologic Malignancies (173)
  2. Department of Medicine (173)
  3. Hematologic Malignancies, Division of (173)
  4. Lymphoma (173)
  5. Population Sciences Research Program (60)
  6. Survivorship Research (44)
  7. Department of Pathology and Laboratory Medicine (26)
  8. Executive Committee, Center for Hematologic Malignancies (26)
  9. Epidemiology and Biostatistics (24)
  10. Sloan Kettering Institute Postdocs (22)
Search Within
  1. "Lymphoma"
Formats
  1. Meeting Abstract (106)
  2. Journal Article (60)
  3. Conference Paper (3)
  4. Research Letter (2)
  5. Book Section (1)
  6. Review (1)
Groups
  1. Center for Hematologic Malignancies (173)
  2. Department of Medicine (173)
  3. Hematologic Malignancies, Division of (173)
  4. Lymphoma (173)
  5. Population Sciences Research Program (60)
  6. Survivorship Research (44)

More Groups

People
  1. Steven Horwitz (55)
  2. David Straus (36)
  3. Alison Moskowitz (31)
  4. Maria Palomba (31)
  5. Andrew Zelenetz (29)
  6. Anas Younes (25)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (23)
  4. 2022 (2)
  5. 2021 (22)
  6. 2020 (2)

More Years

Publications
  1. Hematological Oncology (110)
  2. Cancer (37)
  3. Journal of the American Geriatrics Society (4)
  4. Cancer Medicine (3)
  5. Breast Journal (2)
  6. Cytometry Part B—Clinical Cytometry (2)

More Publications

Results (173)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes
    Research Letter

    Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Horwitz, S. M.; Johnson, W.; Moskowitz, A. J.; Myskowski, P.; Pulitzer, M.; Geller, S.
    Journal of the European Academy of Dermatology and Venereology (2025)

    Fulltext@MSK | Save
  • Differences in ancestry and presence of gastric precursor lesions in individuals with young- and average-onset gastric cancer
    Journal Article

    Magahis, P. T.; Cornet, N.; Tang, L.; Arora, K.; Hingorani, N.; King, S.; Markowitz, A. J.; Schattner, M.; Shimada, S.; Maron, S. B.; more...
    Cancer Medicine (2024)

    Fulltext@MSK | Save
  • Evaluation of bleeding risk in patients who received pirtobrutinib in the presence or absence of antithrombotic therapy
    Journal Article

    Lamanna, N.; Tam, C. S.; Woyach, J. A.; Alencar, A. J.; Palomba, M. L.; Zinzani, P. L.; Flinn, I. W.; Fakhri, B.; Cohen, J. B.; Kontos, A.; more...
    eJHaem (2024)

    Fulltext@MSK | Save
  • Role of flow cytometric immunophenotyping in the diagnosis of breast implant-associated anaplastic large cell lymphoma: A 6-year, single-institution experience
    Journal Article

    Chan, A.; Auclair, R.; Gao, Q.; Ghione, P.; Horwitz, S.; Dogan, A.; Roshal, M.; Lin, O.
    Cytometry Part B—Clinical Cytometry (2024)

    Fulltext@MSK | Save
  • A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trials
    Journal Article

    Kostakoglu, L.; Martelli, M.; Sehn, L. H.; Davies, A.; Trneny, M.; Herold, M.; Vitolo, U.; Hiddemann, W.; Trotman, J.; Knapp, A.; more...
    Ejhaem (2023)

    Fulltext@MSK | Save
  • TRANSCEND FL: Phase 2 study results of lisocabtagene maraleucel (LISO‐CEL) in patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL)
    Meeting Abstract

    Morschhauser, F.; Dahiya, S.; Palomba, M. L.; Garcia‐Sancho, A. M.; Reguera Ortega, J. L.; Kuruvilla, J.; Jager, U.; Cartron, G.; Izutsu, K.; Dreyling, M.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Lisocabtagene maraleucel (LISO‐CEL) in R/R MCL: Primary analysis results from the MCL cohort of the single-arm, multicenter, seamless design transcend NHL 001 study
    Meeting Abstract

    Wang, M.; Siddiqi, T.; Gordon, L. I.; Kamdar, M.; Lunning, M.; Hirayama, A. V.; Abramson, J. S.; Arnason, J.; Ghosh, N.; Mehta, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Daratumumab and EPOCH for HIV+/‐ plasmablastic lymphoma: A feasibility study of the AIDS Malignancy Consortium (AMC 105)
    Meeting Abstract

    Noy, A.; Barta, S. K.; Tan, C. R.; Kwon, D.; Baiocchi, R.; Rubinstein, P.; Ambinder, R.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • A phase I study of split‐course bringing radiotherapy (SC‐BRT) prior to commercial CD19 CAR T‐cell therapies for patients with relapsed or refractory B‐cell lymphomas
    Meeting Abstract

    Imber, B. S.; Yahalom, J.; Palomba, M. L.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19‐targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B‐cell lymphoma
    Meeting Abstract

    Palomba, M. L.; Riviere, I.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E. R.; Liotta, K.; Li, J.; Sellner, L.; Sadelain, M.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save